Tenet Healthcare (THC) Tops Q1 EPS by 87c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Tenet Reports First Quarter 2022 Results; Retired over $800 Million of Debt to Date in 2022; Maintains 2022 Adjusted EBITDA Outlook
April 20, 2022 4:05 PM EDTNet income from continuing operations available to common shareholders in Q122 of $139 million ($135 million excluding grant income) versus net income from continuing operations of $97 million in Q121 ($73 million excluding grant income) Consolidated Adjusted EBITDA in Q122 of $888 million ($882 million excluding $6 million of grant income), exceeding the Company's Q122 Outlook range, versus $777 million in Q121 ($740 million excluding $37 million of grant income); Q1'22 included a $69 million gain from the sale of certain medical office buildings for net cash proceeds of $147 million Diluted earnings per share from... More
